All posts
14550 total · page 43 of 291
Halo Unveils Versatile Sterile Fill-Finish Line
Halo introduces a new platform for sterile fill-finish, accommodating three formats on a single line.
Gland Pharma Enters CDMO Agreement for Sterile Injectables
Gland Pharma partners with a CDMO to enhance its sterile injectables manufacturing capabilities.
BioHarvest Sciences Inks Major Fragrance Contract, Eyes 2027 Profitability
BioHarvest Sciences secures a key fragrance contract, boosting revenue and aiming for 2027 EBITDA breakeven.
BioHarvest Sciences Lowers FY26 Revenue Forecast for CDMO and VINIA D2C
BioHarvest revises FY26 revenue projections downward for its CDMO and VINIA D2C segments, reflecting market challenges.
NITI Aayog Unveils Latest 'Trade Watch Quarterly' Edition
NITI Aayog has released the eighth edition of its 'Trade Watch Quarterly', offering insights into India's trade dynamics.
APIs Revolutionize Access to Real-Time Global Tariff Data
Global trade experts increasingly rely on APIs for accurate, up-to-date tariff information, enhancing decision-making and compliance.
India's Pharma Exports Overtake Imports, Reaching Rs 41,500 Cr in FY25
India's pharmaceutical sector sees a boost as exports of active ingredients surpass imports, marking a significant trade milestone.
Molbio Diagnostics Eyes ₹200 Crore Through IPO Amidst Global Expansion
Molbio Diagnostics plans to raise ₹200 crore via IPO for expansion, while reducing promoter stake to 43%.
Ebola Death Toll Surpasses 2,000 in DRC Amid Vaccine Efforts
Ebola fatalities in the DRC have exceeded 2,000, prompting urgent calls for vaccine development and community-led containment strategies.
Medical Device Firms Oppose Bill Equating Devices with Drugs
India's medical device sector challenges a draft bill treating devices as pharmaceuticals, citing regulatory and innovation concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO Amidst Global Expansion
Molbio Diagnostics is launching an IPO to raise ₹940 crore, aiming to bolster capital expenditures and reduce promoter stake.
Indian Medical Device Industry Rejects Equating Devices with Pharma in New Bill
Industry leaders argue the Draft Bill's pharma-style regulations threaten innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fund Expansion
Molbio Diagnostics seeks to raise ₹940 crore through IPO for expansion and stake reduction, targeting long-term growth.
Medical Device Industry Challenges India's Draft Regulation Bill
India's medical device sector opposes the draft bill treating devices like drugs, citing potential harm to innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Potential Long-Term Gains
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and reduce promoter stake. Investors weigh high-risk, high-reward potential.
Industry Criticizes Draft Bill for Treating Medical Devices as Drugs
The medical device sector opposes the 2026 draft bill, arguing it aligns devices with pharmaceuticals, risking innovation and growth.
Molbio Diagnostics' IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and promoter stake reduction.
Trump Alters Childhood Vaccine Schedule Amid Criticism
President Trump signs an executive order changing the childhood vaccine schedule, sparking controversy.
Medical Device Firms Oppose Draft Bill Treating Devices as Drugs
India's medical device sector challenges draft bill equating devices with pharmaceuticals, fearing impacts on innovation and investment.
Bangladesh to Launch Nationwide Health Screening Initiative
Bangladesh is set to introduce a door-to-door health screening program, aiming to improve access to medical care across the country.
Beyond Checkups: Comprehensive Health for Executives Gains Urgency
Executives are shifting towards comprehensive health strategies that extend beyond routine checkups to safeguard their well-being.
Health Challenges Loom Over U.S. C-Suite Executives
U.S. executives face increasing health issues, impacting business productivity.
Ivory Launches Initiative to Screen for Mental Health Risks
Ivory introduces a proactive brain screening program to detect mental health issues before they manifest.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, aiming to bolster its global diagnostics footprint.
Healthcare Shift Workers Face Increased Respiratory Infections
Shift workers in healthcare see a rise in respiratory infections, raising health concerns.
Delhi Sees Alarming Six-Fold Surge in H1N1 Cases
Delhi reports a dramatic rise in H1N1 cases, surging six-fold compared to last year, raising health concerns.
Rise in Lung Cancer Cases Among Non-Smokers Raises Alarm
Lung cancer is increasingly affecting non-smokers due to factors like air pollution and genetic predispositions.
AI Breakthrough Offers New Fertility Hope for Men with Low Sperm Counts
AI technology is revolutionizing fertility treatment by identifying viable sperm in men with low sperm counts, enhancing chances for biological parenthood.
Medical Device Sector Challenges India's New Regulatory Bill
Industry opposes treating devices as drugs in the draft Drugs, Medical Devices, and Cosmetics Bill 2026.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, aiming to expand and reduce promoter stake.
Medical Device Industry Pushes Back Against India's Draft Bill 2026
India's medical device sector challenges the 2026 Draft Bill, warning it stifles innovation by equating devices with pharmaceuticals.
Molbio Diagnostics Eyes ₹940 Crore from IPO, Targets High-Risk Investors
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device industry rejects draft bill equating devices to drugs, citing risks to innovation and investment.
Molbio Diagnostics Eyes ₹200 Crore IPO for Expansion Amid Growth
Molbio Diagnostics plans a ₹200 crore IPO to boost capital expenditures and reduce promoter stake, following strong revenue growth.
Rising Recall Fatigue Amid Surging Food Safety Alerts
Amid a surge in food recalls, consumers grow weary as cyclospora and salmonella outbreaks trouble major food chains.
Expert Insights: Debunking Myths on Water Intake and Sleep
Dr. John Torres addresses common health myths, focusing on water intake and sleep advice.
Industry Pushback Against India's Draft Bill on Medical Devices
India's medical device sector opposes a draft bill treating devices like drugs, citing potential harm to growth and innovation.
Civil Hospital Achieves Milestone with First Neurosurgery Operation
Civil Hospital marks a historic achievement by performing its first neurosurgery, enhancing specialized healthcare services at the district level.
UHealth Neurology and Neurosurgery Program's Excellence Recognized
UHealth's neurology and neurosurgery program at the University of Miami is acclaimed for its advanced patient care and innovative research.
NFID Highlights Importance of Adhering to Childhood Immunization Schedule
The NFID emphasizes the critical role of vaccines in children's health, urging adherence to recommended schedules.
TB Vaccine Development Reaches New Heights Amid Renewed Efforts
Progress in TB vaccine research marks a pivotal advancement, showing promise after decades.
Rising Floodwaters Heighten Infectious Disease Threats in Europe
Intense floods in Europe are elevating risks of infectious diseases, prompting health alerts.
Molbio Diagnostics Eyes ₹940 Crore from IPO Amid Growth Surge
Molbio Diagnostics plans to raise ₹940 crore via IPO to fund expansion and reduce promoter stake. Revenue from TB test kits drives substantial growth.
Advancements in Lewy Body Dementia: Diagnosis and Treatment
New insights into Lewy Body Dementia offer hope for improved diagnosis and targeted therapies.
Trump's Executive Order Challenges Childhood Vaccine Protocols
President Trump issues an order seeking reduced childhood vaccines, sparking debate over its legal impact.
Industry Pushback: Medical Devices Not Pharmaceuticals, Say Companies
India's medical device sector challenges a draft bill treating devices as drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Seeks ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics aims to raise ₹940 crore through IPO for growth and reducing promoter stake, targeting high-risk investors.
Medical Device Industry Opposes Indian Draft Bill on Drug Regulation
Industry groups argue that the 2026 draft bill unfairly equates medical devices with pharmaceuticals, risking innovation and investment.
Molbio Diagnostics IPO Targets ₹940 Crore Amid Tuberculosis Test Kit Success
Molbio Diagnostics eyes ₹940 crore via IPO for expansion and reduced promoter stake, driven by TB test kit sales.
Adult-Onset Hydrocephalus Linked to Increased Epilepsy Risk: UK Study
UK Biobank research reveals a higher epilepsy risk in adults with acquired hydrocephalus.